GB-5267 - IV only
I-4601225
Phase 1 mab active
Quick answer
GB-5267 - IV only for Platinum-resistant Ovarian Cancer is a Phase 1 program (mab) at Generate Biomedicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Generate Biomedicines
- Indication
- Platinum-resistant Ovarian Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- active